Cargando…
Landscape Analysis of Breast Cancer and Acute Myeloid Leukemia Trials Using the My Cancer Genome Clinical Trial Data Model
PURPOSE: The field of oncology is expanding rapidly. New trials are opening as an increasing number of therapeutic agents are being investigated before they can become approved therapies. Aggregate views of these data, particularly data associated with diseases, biomarkers, and drugs, can be helpful...
Autores principales: | Jain, Neha M., Holt, Marilyn, Micheel, Christine, Levy, Mia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807022/ https://www.ncbi.nlm.nih.gov/pubmed/34546785 http://dx.doi.org/10.1200/CCI.21.00082 |
Ejemplares similares
-
The My Cancer Genome clinical trial data model and trial curation workflow
por: Jain, Neha, et al.
Publicado: (2020) -
My Cancer Genome: Coevolution of Precision Oncology and a Molecular Oncology Knowledgebase
por: Holt, Marilyn E., et al.
Publicado: (2021) -
The Path(way) Less Traveled: A Pathway-Oriented Approach to Providing Information about Precision Cancer Medicine on My Cancer Genome()()
por: Taylor, Alexandria D., et al.
Publicado: (2016) -
Conceptual Framework to Support Clinical Trial Optimization and End-to-End Enrollment Workflow
por: Jain, Neha M., et al.
Publicado: (2019) -
Learnings From Precision Clinical Trial Matching for Oncology Patients Who Received NGS Testing
por: Jain, Neha M., et al.
Publicado: (2021)